...
首页> 外文期刊>Journal of Oral Science >HLA-A*26-A*30 and HLA-DRB1*10 could be predictors of nasopharyngeal carcinoma risk in high-risk Tunisian families
【24h】

HLA-A*26-A*30 and HLA-DRB1*10 could be predictors of nasopharyngeal carcinoma risk in high-risk Tunisian families

机译:HLA-A * 26-A * 30和HLA-DRB1 * 10可能是突尼斯高危家庭鼻咽癌风险的预测因子

获取原文
           

摘要

We investigated human leukocyte antigen (HLA) profiles for Tunisians with nasopharyngeal carcinoma (NPC), their families, and a sample of unrelated healthy Tunisians in order to identify HLA specificities associated with familial NPC. HLA-A, -B, and -DRB1 typing was successful for 36 NPC patients, 72 unaffected family members, and 130 community controls, and the chi square or Fisher exact test was used to compare allele frequencies between cases and controls. We observed a consistent protective effect of HLA-DRB1*10 on NPC development. However, none of the NPC patients or their family members had a positive result for this HLA marker (0% vs 9.2% in controls, P = 0.047). In addition, HLA-A*26 was probably an induction marker, as its allelic frequency was significantly higher among NPC patients than among controls ( P = 0.003) and among NPC patients than among at-risk family members ( P = 0.067). Logistic regression analysis of the joint effect of selected HLA specificities showed that HLA-A*26 and HLA-A*30 were co-associated and have an important effect on NPC risk. Despite the small size of our cohort, we showed that HLA-A*26-A*30 and HLA-DRB1*10 might be predictive markers for NPC screening of Tunisian families with a high risk of NPC.
机译:我们调查了鼻咽癌(NPC)的突尼斯人,他们的家庭和不相关的健康突尼斯人的样本的人类白细胞抗原(HLA)谱,以鉴定与家族性NPC相关的HLA特异性。 HLA-A,-B和-DRB1分型成功用于36位NPC患者,72位未受影响的家庭成员和130位社区对照,并且卡方检验或Fisher精确检验用于比较病例与对照之间的等位基因频率。我们观察到HLA-DRB1 * 10对NPC发育具有一致的保护作用。但是,没有任何NPC患者或其家属对该HLA标记物有阳性结果(对照组中0%比9.2%,P = 0.047)。此外,HLA-A * 26可能是诱导标记,因为其等位基因频率在NPC患者中显着高于对照组(P = 0.003),在NPC患者中也比高危家庭成员(P = 0.067)高。对选定的HLA特异性的联合作用进行Logistic回归分析表明,HLA-A * 26和HLA-A * 30相互关联,并且对NPC风险具有重要影响。尽管我们的研究小组规模很小,但我们显示HLA-A * 26-A * 30和HLA-DRB1 * 10可能是突尼斯人NPC风险高的NPC筛查的预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号